Chris Degnan

Chris Degnan

Director of Finance/CFO at GALERA THERAPEUTICS, INC.

Net worth: 1 400 $ as of 30/03/2024

44 year
Health Technology
Consumer Services

Profile

Chris Degnan is currently the Chief Financial & Accounting Officer at Galera Therapeutics, Inc. He previously worked as a Senior Finance Director at AstraZeneca PLC from 2004 to 2014.
From 2014 to 2018, he served as the Chief Financial Officer at Endo International Plc.
He also held the position of Chief Financial Officer & Vice President-Finance at Endo Pharmaceuticals, Inc. Additionally, he worked as the Chief Financial & Accounting Officer at Verrica Pharmaceuticals, Inc. from 2018 to 2019.
Mr. Degnan completed his undergraduate degree at the University of Notre Dame.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
20/04/2023 10,000 ( 0.02% ) 1 400 $ 30/03/2024

Chris Degnan active positions

CompaniesPositionStart
GALERA THERAPEUTICS, INC. Director of Finance/CFO 20/10/2019
All active positions of Chris Degnan

Former positions of Chris Degnan

CompaniesPositionEnd
VERRICA PHARMACEUTICALS INC. Director of Finance/CFO 06/10/2019
ENDO INTERNATIONAL PLC Director of Finance/CFO 28/02/2018
ASTRAZENECA PLC Director of Finance/CFO 31/10/2014
Director of Finance/CFO -
See the detail of Chris Degnan's experience

Training of Chris Degnan

University of Notre Dame Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chris Degnan's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
ASTRAZENECA PLC

Health Technology

GALERA THERAPEUTICS, INC.

Health Technology

ENDO INTERNATIONAL PLC

Health Technology

VERRICA PHARMACEUTICALS INC.

Health Technology

Private companies1

Health Technology

See company connections